Seeing Is Believing
Currently out of the existing stock ratings of Kristen Kluska, 102 are a BUY (91.89%), 9 are a HOLD (8.11%).
Analyst Kristen Kluska works at CANTOR FITZGERALD with a stock forecast success ratio of 40.91% fulfilled within 103.25 days on average.
Kristen Kluska’s has documented 214 price targets and ratings displayed on 29 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on ABEO, Abeona Therapeutics at 23-Apr-2024.
Analyst best performing recommendations are on OCGN (OCUGEN).
The best stock recommendation documented was for OCGN (OCUGEN) at 2/3/2021. The price target of $4 was fulfilled within 2 days with a profit of $1.19 (42.35%) receiving and performance score of 211.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
90
$52.98 (143.11%)
72
1 months 29 days ago
0/4 (0%)
$38.96 (76.33%)
Hold
27
$-10.02 (-27.07%)
21
5 months 15 days ago
1/2 (50%)
$0.06 (0.22%)
4
Buy
80
$42.98 (116.10%)
73
5 months 19 days ago
6/15 (40%)
$50.65 (172.57%)
256
Buy
52
$14.98 (40.46%)
54
5 months 22 days ago
4/11 (36.36%)
$26.02 (100.15%)
62
Buy
68
$30.98 (83.68%)
70
8 months 14 days ago
0/3 (0%)
$37.77 (124.94%)
Which stock is Kristen Kluska is most bullish on?
Which stock is Kristen Kluska is most reserved on?
What Year was the first public recommendation made by Kristen Kluska?